Anti-Cancer Agents and Biological Therapy

Access all ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Tumour Knowledge Portal

Preselected recommended educational resources on this topic

ESMO Clinical Practice Guidelines

Clinical Practice Guidelines block

Check the Clinical Practice Guidelines by Tumour Type to find recommendations

ESMO Handbook on Clinical Pharmacology of Anti-Cancer Agents

2012 ESMO Handbook of Clinical Pharmacology of Anti-Cancer Agents


Browse through the content online (ESMO members only)

Elisabeth de Vries (Chair of the ESMO Magnitude of Clinical Benefit Scale Working Group) and George Pentheroudakis (Chair of the ESMO Guidelines Committee) explain how newly registered drugs are graded according to the ESMO-MCBS, and how scores are integrated into the ESMO Clinical Practice Guidelines.

Drug-Drug Interactions with Kinase Inhibitors

This section has been developed as a comprehensive resource providing information for healthcare professionals on the management of kinase inhibitor-associated drug-drug interactions. It also includes information for patients.

Access practice tool